Barclays raised the firm’s price target on Synovus (SNV) to $67 from $60 and keeps an Overweight rating on the shares as part of a Q2 earnings preview for the mid-cap banks. The firm believes valuations in the group still largely underappreciate an improving operating and regulatory backdrop.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNV:
